Pfizer
Patents, Design & Utilities
Last updated:
List of all Pfizer patents 451 in total
| Status | Patent |
|---|---|
Application | Utility: RECOMBINANT VACCINIA VIRUS Filling date: 13 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: Combinations For Treatment Of NASH/NAFLD And Related Diseases Filling date: 13 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: BTLA FUSION PROTEIN AGONISTS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: THERAPEUTIC ANTIBODIES AND THEIR USES Filling date: 13 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof Filling date: 13 Sep 2025 Issue date: 20 Jan 2022 |
Grant | Utility: Cyclin dependent kinase inhibitors Filling date: 13 Sep 2025 Issue date: 11 Jan 2022 |
Grant | Utility: Substituted n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as protein kinase C inhibitors Filling date: 13 Sep 2025 Issue date: 11 Jan 2022 |
Application | Utility: IMMUNOGENIC COMPOSITIONS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: BINDING MOLECULES TO THE HUMAN OX40 RECEPTOR Filling date: 13 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: AMINOPYRIMIDINYL DERIVATIVES Filling date: 13 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: ANTIBODIES TO COAGULATION FACTOR XIA AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 30 Dec 2021 |
Grant | Utility: Compositions and methods relating to a mutant Clostridium difficile toxin Filling date: 13 Sep 2025 Issue date: 28 Dec 2021 |
Application | Utility: Immunogenic Compositions for Use in Pneumococcal Vaccines Filling date: 13 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: Dosage Regimen for TFPI Antagonists Filling date: 13 Sep 2025 Issue date: 23 Dec 2021 |
Grant | Utility: Anti-proliferative agents for treating PAH Filling date: 13 Sep 2025 Issue date: 21 Dec 2021 |
Application | Utility: CRYSTALLINE FORMS OF LORLATINIB MALEATE Filling date: 13 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: POLYMORPH FORM OF A MONOPHOSPHATE HYDRATE SALT OF A KNOWN TETRAHYDROISOQUINOLINE DERIVATIVE Filling date: 13 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: Combination for Treating Cancer Filling date: 13 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: PYRROLO[2,3-D]PYRIMIDINE TOSYLATE SALT, CRYSTALLINE FORM THEREOF AND MANUFACTURING PROCESS AND INTERMEDIATES THERETO Filling date: 13 Sep 2025 Issue date: 16 Dec 2021 |
Grant | Utility: Aminopyrimidinyl compounds Filling date: 13 Sep 2025 Issue date: 14 Dec 2021 |
Grant | Utility: Dihydro-pyrrolo-pyridine derivatives Filling date: 13 Sep 2025 Issue date: 14 Dec 2021 |
Application | Utility: GLYCOCONJUGATION PROCESS Filling date: 13 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: AMINOPYRIMIDINYL COMPOUNDS Filling date: 13 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: Combinations for Treating Cancer Filling date: 13 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: COMPOUNDS AND USES THEREOF TO TREAT TUMORS IN A SUBJECT Filling date: 13 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: NOVEL IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS Filling date: 13 Sep 2025 Issue date: 18 Nov 2021 |
Grant | Utility: Vectors for expression of prostate-associated antigens Filling date: 13 Sep 2025 Issue date: 16 Nov 2021 |
Application | Utility: COMBINATIONS OF TGF-BETA INHIBITORS AND CDK INHIBITORS FOR CANCER TREATMENTS Filling date: 13 Sep 2025 Issue date: 11 Nov 2021 |
Grant | Utility: Crystalline forms of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyan- ophenyl)urea maleate Filling date: 13 Sep 2025 Issue date: 9 Nov 2021 |
Grant | Utility: Cyclic substituted imidazo[4,5-c]quinoline derivatives Filling date: 13 Sep 2025 Issue date: 2 Nov 2021 |
Grant | Utility: Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof Filling date: 13 Sep 2025 Issue date: 2 Nov 2021 |
Application | Utility: GLP-1 Receptor Agonists and Uses Thereof Filling date: 13 Sep 2025 Issue date: 28 Oct 2021 |
Grant | Utility: Therapeutic antibodies and their uses Filling date: 13 Sep 2025 Issue date: 26 Oct 2021 |
Application | Utility: IL-15 Variants and Uses Thereof Filling date: 13 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: Dosage Regimen For MAdCAM Antagonists Filling date: 13 Sep 2025 Issue date: 21 Oct 2021 |
Grant | Utility: Immunogenic compositions and uses thereof Filling date: 13 Sep 2025 Issue date: 19 Oct 2021 |
Grant | Utility: Engineered antibody constant regions for site-specific conjugation and methods and uses therefor Filling date: 13 Sep 2025 Issue date: 19 Oct 2021 |
Application | Utility: SOLID DOSAGE FORMS OF PALBOCICLIB Filling date: 13 Sep 2025 Issue date: 14 Oct 2021 |
Grant | Utility: Azalactam compounds as HPK1 inhibitors Filling date: 13 Sep 2025 Issue date: 12 Oct 2021 |
Application | Utility: DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS Filling date: 13 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: 5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES Filling date: 13 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: SOLUBLE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (SFGFR3) POLYPEPTIDES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS Filling date: 13 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: Heterocyclic Spiro Compounds As MAGL Inhibitors Filling date: 13 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: HETEROARYL SULFONE-BASED CONJUGATION HANDLES, METHODS FOR THEIR PREPARATION, AND THEIR USE IN SYNTHESIZING ANTIBODY DRUG CONJUGATES Filling date: 13 Sep 2025 Issue date: 7 Oct 2021 |
Grant | Utility: Immunogenic compositions for use in pneumococcal vaccines Filling date: 13 Sep 2025 Issue date: 5 Oct 2021 |
Application | Utility: HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS Filling date: 13 Sep 2025 Issue date: 30 Sep 2021 |
Grant | Utility: Glycoconjugation process Filling date: 13 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Glycoconjugation processes and compositions Filling date: 13 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Prostate-associated antigens and vaccine-based immunotherapy regimens Filling date: 13 Sep 2025 Issue date: 7 Sep 2021 |
Showing 50 to 100 of 451 patents.